Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @FishburnSimone
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FishburnSimone
-
Simone Fishburn proslijedio/la je Tweet
$GILD to begin enrolling patients mid-Feb in 2 trials of#remdesivir to treat#2019nCoV acute respiratory disease via@BioCentury's@LaboratoryLiz https://www.biocentury.com/article/304364 pic.twitter.com/dLlAnArZS7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Simone Fishburn proslijedio/la je Tweet
BioCentury is providing open access to its ongoing coverage and analysis of the
#2019CoV outbreak.https://www.biocentury.com/coronavirusHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GSK to provide adjuvant to boost effectiveness, stretch supplies of
#2019nCoV vaccines. In@BioCentury (No paywall) https://www.biocentury.com/article/304359 pic.twitter.com/bwyXsBfYdV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Gilead prepares for Chinese trial of antiviral after treating U.S. patient. In
@biocentury (no paywall) https://www.biocentury.com/article/304364 pic.twitter.com/K1iEG6tzOT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Clinical trials for coronavirus have begun. First up: approved antivirals and steroids. In
@BioCentury (No paywall) https://www.biocentury.com/article/304368 pic.twitter.com/HBDaS4Ga2k
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Coronavirus outbreak: Letter from the Editor.
@biocentury#2019nCoV — coverage on biomedical countermeasures; effect on clinical trials and supply chain; and more. Free to all, no paywall. https://www.biocentury.com/article/304366 pic.twitter.com/BUkvSIA03I
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Simone Fishburn proslijedio/la je Tweet
Gilead preparing a trial in China of remdesivir to treat 2019-nCoV: https://www.biocentury.com/article/304364 . Meanwhile, at least 9 trials of #2019-nCoV therapies are underway. https://www.biocentury.com/article/304364 All BioCentury coverage of the outbreak is in front of the paywall at https://www.biocentury.com/coronavirus .pic.twitter.com/MR9Bhpq0Pn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Simone Fishburn proslijedio/la je Tweet
A milestone year for Roche's CNS gambit could kick off its plan for the decade - BioCentury: A milestone year for Roche's CNS gambit could kick off its plan for the decade BioCenturyhttp://dlvr.it/RPHwyJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Folks -
@BioCentury is continuing to cover the#Coronavirus outbreak, which is outside the paywall. This contains the therapeutic & preventive developments, policy actions, and biopharma response.https://www.biocentury.com/coronavirusHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Well that’s a wrap on Europe for the UK (
). But UK biotech still wants to tango. We‘ve got the companies, you’ve got the regulators- let’s dance. @StephenPHansen with the story, in@BioCentury.https://www.biocentury.com/article/304340Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Simone Fishburn proslijedio/la je Tweet
A dozen #2019-nCoV vaccine development programs have been announced, five efforts to discover and develop therapeutic antibodies.
@V2019N https://www.biocentury.com/bc-extra/clinical-news/2020-01-30/industry-and-academic-centers-are-rushing-create-new-vaccines-and- …pic.twitter.com/GWcSDuBcZg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CVS eliminating co-pays for insulin and diabetes meds. A step in the right direction say biopharma leaders who want to uphold the social contract. Via
@Laurenmmartz in@BioCenturyhttps://www.biocentury.com/bc-extra/politics-policy/2020-01-29/industry-leaders-applaud-cvs-zero-co-pay-diabetes-drug-access …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Had the pleasure of doing a Fireside Chat with
@snbhatia at#JPM2020, and she is certainly moving the needle on this issue. Having a successful academic entrepreneur speak out is huge. A name to watch in all events.https://www.washingtonpost.com/science/2020/01/29/bias-biotech-funding-has-blocked-women-led-companies/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
One class act is this
@EMcCallister01! We hand her off to PwC with the warmest of wishes, knowing she will excel there as she does everywhere. She leaves a great legacy@biocentury, and@Laurenmmartz will extend her leadership, covering now translation to clin dev.https://twitter.com/EMcCallister01/status/1222278324535418880 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I’m too old for this
#Federer, seriously. Unbelievable champion.@AustralianOpenHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Simone Fishburn proslijedio/la je Tweet
Biocentury articles are really top notch
#Cart#celltherapy landscapes with target antigenspic.twitter.com/LeXQCG2hBT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With all eyes on the
#WuhanCoronavirus outbreak,@steveusdin1 and@_Ktktktktk have an in-depth look at how biotechs are tackling it -- faster and broader than for previous outbreaks. Via@BioCentury.#nCoV2019https://www.biocentury.com/biocentury/product-development/2020-01-24/coronavirus-outbreak-creating-testbed-new-vaccine-and- …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Want to know who’s doing what to get CAR Ts to solid tumors? Winnie Pong has sliced and diced the data in
@BioCentury. Take-home message: the majority are going after non-validated targets. Less of the lemming factor than in other areas of IO.https://www.biocentury.com/biocentury/targets-mechanisms/2020-01-24/targets-and-indications-car-t-developers-are-exploring--0 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The text you never want to get: “check your car for swastikas.” Husband found this on his. Really
@RedwoodCity ??pic.twitter.com/tTaG6LiRML
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Simone Fishburn proslijedio/la je Tweet
.
@NIHDirector Francis Collins gets out his crystal ball and looks ahead to 2020 in this nice interview with Karen Tkach Tuzman of@BioCentury:https://bit.ly/30v6H1THvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.